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Central nervous system (CNS) risks which include during space missions and lifetime risks due to space 
radiation exposure are of concern for long-term exploration missions to Mars or other destinations. 
Possible CNS risks during a mission are altered cognitive function, including detriments in short-term 
memory, reduced motor function, and behavioral changes, which may affect performance and human 
health. The late CNS risks are possible neurological disorders such as premature aging, and Alzheimer’s 
disease (AD) or other dementia. Radiation safety requirements are intended to prevent all clinically 
signiﬁcant acute risks. However the deﬁnition of clinically signiﬁcant CNS risks and their dependences 
on dose, dose-rate and radiation quality is poorly understood at this time. For late CNS effects such 
as increased risk of AD, the occurrence of the disease is fatal with mean time from diagnosis of early 
stage AD to death about 8 years. Therefore if AD risk or other late CNS risks from space radiation occur 
at mission relevant doses, they would naturally be included in the overall acceptable risk of exposure 
induced death (REID) probability for space missions. Important progress has been made in understanding 
CNS risks due to space radiation exposure, however in general the doses used in experimental studies 
have been much higher than the annual galactic cosmic ray (GCR) dose (∼0.1 Gy/y at solar maximum 
and ∼0.2 Gy/y at solar minimum with less than 50% from HZE particles). In this report we summarize 
recent space radiobiology studies of CNS effects from particle accelerators simulating space radiation 
using experimental models, and make a critical assessment of their relevance relative to doses and dose-
rates to be incurred on a Mars mission. Prospects for understanding dose, dose-rate and radiation quality 
dependencies of CNS effects and extrapolation to human risk assessments are described.
© 2014 The Committee on Space Research (COSPAR). Published by Elsevier Ltd. This is an open access 
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Experimental studies at particle accelerators with protons and 
high charge and energy (HZE) nuclei have suggested that during 
mission and late risks to the central nervous system (CNS) from 
galactic cosmic rays (GCR) and solar particle events (SPEs) could 
be a limitation to human exploration of our solar system (NAS, 
1973, 1996; NCRP, 2006; Cucinotta et al., 2009). However, there 
remains an important scientiﬁc challenge of extrapolating observa-
tions from these studies to humans and vital need to perform new 
experiments at space relevant doses and dose-rates to understand 
the during mission and late CNS risks. Because of the relatively 
low doses of space missions (<0.5 Gy), the early (during mission) 
space radiation CNS risks will likely be distinct compared to acute 
and delayed radiation injury that occur after very high doses of 
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(http://creativecommons.org/licenses/by-nc-nd/3.0/).radiation (Toﬁlon and Fike, 2000). In addition, for during mission 
CNS risks there are potentially synergistic interactions with other 
spaceﬂight factors such as altered circadian rhythm and micrograv-
ity. In this review, we ﬁrst summarize exposures to be encountered 
on Mars missions which show the maximum annual exposure from 
GCR to be no more than 0.2 Gy/y with less than 50% from HZE 
particles. Existing human data on CNS risks at low to moderate 
doses (<2 Gy) are brieﬂy summarized. Recent studies in CNS ra-
diobiology are then discussed, and recommendations on how to 
deﬁne new exposure conditions for CNS research to ensure their 
relevance for space conditions are discussed.
Radiation protection both on Earth and in space (NCRP, 1989) is 
based on principles of risk justiﬁcation and limitation. For stochas-
tic effects such as cancer, acceptable risks are set with an upper 
limit of 1 in 33 probability of cancer mortality from occupational 
exposures (NCRP, 1989, 2000) using the quantity risk of exposure 
induced death (REID) (Cucinotta et al., 2013a, 2013b; Cucinotta, 
2014). This compares with the current estimate of 1 in 270 for 
loss of crew due to ﬂight failures, while new technology invest-
ments expected to reduce this value to 1 in 750 (ASAP, 2010). 
Dose limits for deterministic effects including risks to the skin, td. This is an open access article under the CC BY-NC-ND license 
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with limits set at estimated doses below a likely threshold for 
clinically signiﬁcant effects. Deterministic effects are expected to 
occur only above a dose threshold after a signiﬁcant number of 
cells are damaged within a tissue, and with a severity that in-
creases with dose, including an inverse correlation between dose 
and latency. The Casarett model of late tissue effects (Rubin and 
Casarett, 1968; Cox et al., 1983) suggests that signiﬁcant effects 
will occur at lower doses, but with increased latency compared 
to higher doses. Recent debate has considered if cataracts will 
occur without a dose threshold (ICRP, 2012). The increased inci-
dence of cataracts observed after the low space radiation doses of 
past space missions (Cucinotta et al., 2001, Chylack et al., 2009;
Chylack et al., 2012), where only a small fraction of cells in a tis-
sue are damaged, suggests that new paradigms for deterministic 
effects should be considered. More extensive considerations may 
be needed for cognitive changes in the CNS that may occur during 
ﬂight, which likely involve distinct biological factors compared to 
other tissues related to changes to synapse plasticity and distinct 
modes of oxidative damage.
In the past, limiting the risks to the CNS of adults exposed to 
low to moderate doses of ionizing radiation has not been a con-
cern for occupational radiation exposure. CNS injury that occurs 
after high doses of radiation used in radiotherapy, including early 
delayed effects such as demyelination and late delayed effects such 
as vascular damage and white matter necrosis, are not a concern 
for spaceﬂight (Toﬁlon and Fike, 2000; Hopewell, 1994). However, 
the HZE particle component of space radiation presents distinct 
biophysical challenges to cells and tissues compared to terrestrial 
forms of radiation. Soon after the discovery of cosmic rays, the 
concern for CNS risks originated with the prediction of the light 
ﬂash phenomenon from single HZE nuclei traversals of the retina 
(Tobias, 1952), which was later conﬁrmed by the Apollo astronauts. 
HZE nuclei are capable of producing a column of heavily damaged 
cells along their path through tissues, described as a microlesion 
(NAS, 1973; Todd, 1989), possibly leading to negative impacts on 
CNS function. In the last decade new hypotheses for mechanisms 
of HZE damage to the CNS have been described related to the 
observation of cognitive changes, the impacts by HZE nuclei on 
neurogenesis, and pathological changes related to Alzheimer’s dis-
ease and other late effects in experimental studies of the CNS.
Human epidemiology is used as a basis for risk estimation for 
cancer, acute radiation risks, and cataracts using dose-response 
models from low LET exposures in humans combined with quality 
factors or relative biological effectiveness (RBE) factors and dose-
rate modiﬁers determined from experimental models. However, 
this approach is not viable for estimating CNS risks from space 
radiation because there is no human data from low LET radia-
tion exposure to develop a quantitative scaling approach for space 
radiation, and it is likely that HZE particles produce qualitatively 
different biological damage compared to X-rays or gamma-rays. 
At doses above a few Gy, detrimental CNS changes occur in hu-
mans treated with radiation (such as photons and protons) for 
cancer. Here treatment doses of 50 Gy or more are typical, which 
is well above the exposures in space even if a large SPE were to 
occur. Thus, of the categories of space radiation risks, which in-
cludes cancer, CNS, degenerative tissue effects, and acute radiation 
syndromes, CNS risk assessment will rely most extensively on ex-
perimental data with animals for its evidence base, and for the 
development of risk projection models.
2. CNS exposures in space
Both GCR and SPEs are of concern for CNS risks. The GCR 
are composed of protons, helium nuclei, and high charge and en-
ergy (HZE) nuclei. GCR energies ranging from less than 10 MeV/u Table 1
Comparison of NSCR-2012 model to MSL Rad measurements for average dose-rate 
and dose equivalent rate on cruise phase to Mars and on Martian surface.
GCR dose rate 
(mGy/d)
GCR dose eQUIV rate 
(mSv/d)
Model Cruise to Mars* 0.445 1.80
Model Mars surface* 0.20 0.72
RAD cruise to Mars
(Zeitlin et al., 2013)
0.481 ± 0.08 1.84 ± 0.33
RAD Mars surface
(Hassler et al., 2014)
0.205 ± 0.05 0.70 ± 0.17
* NSCR-2012 model predictions (Cucinotta et al., 2013a; Kim et al., 2014).
to above 10,000 MeV/u with median energies inside tissue of 
about 1500 MeV/u for HZE components and several hundred MeV 
for protons and helium nuclei. Secondary particles are produced 
through nuclear reaction in shielding and tissue, including neu-
trons, protons, helium nuclei, mesons and gamma-rays. The high 
energies of GCR lead to practical ranges to 100’s of cm of any ma-
terial, thus precluding radiation shielding as an important mitiga-
tion approach to GCR risks on the CNS. For SPEs, the possibility ex-
ists for an absorbed dose of over 1 Gy from a SPE if the crew is in a 
thinly shielded spacecraft or during a spacewalk (Kim et al., 2007;
Kim et al., 2009) with the likelihood of a SPEs higher near so-
lar maximum and lowest near solar minimum. The energies of 
SPE (10’s to 100’s of MeV), however, do not preclude radiation 
shielding as a potential countermeasure. Nevertheless, the costs of 
shielding may be too high to protect against the largest events that 
have occurred historically (Kim et al., 2009).
GCR dose-rates are accurately predicted by the NASA Space 
Cancer Risk Model (NSCR-2012) (Cucinotta et al., 2013a, 2013b) 
as shown in previous reports comparing to ﬂight measurements 
(Cucinotta et al., 2008; Cucinotta et al., 2013a; Zeitlin et al., 2013;
Kim et al., 2014). Table 1 shows comparison to the recent measure-
ments on the cruise from Earth to Mars, and Martian surface from 
the MSL-RAD detector (Zeitlin et al., 2013; Hassler et al., 2014). 
A high level of agreement between measurements and NSCR-2012 
is found. Fig. 1 (Panel A) shows the variation of the GCR dose-
rate as predicted by the NSCR-2012 model (Cucinotta et al., 2013a, 
2013b). In Fig. 1 (Panel B) the contributions to the annual ab-
sorbed dose versus the charge number of the particle for several 
locations within the human brain are shown for the GCR at solar 
minimum. It is clear that in interplanetary space annual GCR or-
gan doses will vary from about 0.1 Gy to 0.2 Gy per year for solar 
maximum to solar minimum, respectively and the HZE contribu-
tion to the absorbed doses will be 0.1 Gy/y or less (Cucinotta and 
Durante, 2006; Cucinotta et al., 2013a, 2013b). Round-trip times to 
Mars are approximately 1-year, however there are also exposures 
on the surface of Mars with about half the free space dose-rate
(Cucinotta et al., 2007; Hassler et al., 2014). These doses will have 
lower percent-contributions from HZE particles due to their ab-
sorption in the Martian atmosphere and an increased contribution 
from neutrons (Kim et al., 2014). Unfortunately many reports from 
CNS space radiobiology confuse reported estimates of absorbed 
dose with dose equivalent, and use estimates of dose equivalent 
to determine lower dose ranges for experimental design. Because 
average quality factors for GCR are ∼4, such studies are often con-
sidering minimal doses well above the annual GCR doses from HZE 
particles, while not addressing dose-rate effects.
3. Effects in humans and non-human primates at low to 
moderate doses
3.1. CNS risks after cancer therapy with radiation
Evidence of the effects of terrestrial forms of ionizing radi-
ation on the CNS has been documented from the patients of 
56 F.A. Cucinotta et al. / Life Sciences in Space Research 2 (2014) 54–69Fig. 1. (Panel A) NSCR-2012 model (Cucinotta et al., 2013a, 2013b) predictions for 
the annual GCR dose for 20 g/cm2 aluminum shielding using Badhwar–O’Neill envi-
ronmental models: BO96 model or BO11 model with or without dose contributions 
from pions and EM decays (photons, muons, and electrons). (Panel B) NSCR-2012 
model predictions of increasing charge number, Z group contributions. target frag-
ments (TF) (Z > 2), and sum over all projectile like and projectile like fragments 
in tissue to annual GCR absorbed doses at solar minimum for the front, middle, 
and back of human brain. Neutron contributions shown include only Z > 2 recoils 
and fragments, with Z = 1 and 2 fragments produced by neutrons shown combined 
with other sources for Z = 1 and 2 particles.
radiotherapy, although the dose is higher than would be expe-
rienced in the space environment. CNS behavioral changes such 
as chronic fatigue and depression occur in patients undergoing ir-
radiation for cancer therapy. Neurocognitive effects are observed 
at lower doses, especially in children (Schultheiss et al., 1995;
BEIR-V, 1990). A review on intelligence and the academic achieve-
ment of children after treatment for brain tumors indicates that ra-
diation is related to a decline in intelligence and academic achieve-
ment, including low score of intelligence quotients (IQ), verbal, 
performance IQ, as well as in academic achievement in reading, 
spelling and mathematics, and attention functioning (Butler and 
Haser J, 2006). Mental retardation was observed in the children of 
the atomic-bomb survivors in Japan exposed prenatally at mod-
erate doses (<2 Gy) at 8–15 weeks post-conception, but not at 
earlier or later times since conception (BEIR-V, 1990).
Radiotherapy for treatment of several types of tumors with 
protons and other charged particle beams provides ancillary 
data for considering radiation effects for the CNS. As reviewed 
in NCRP Report No. 153 (NCRP, 2006) radiotherapy data exists for treatment of pituitary tumors (Kjellberg and Kliman, 1979;
Linfoot, 1979), hormone-responsive metastatic mammary carci-
noma (Tobias, 1979), brain tumors (Castro et al., 1985; Suit 
et al., 1982), and intracranial arteriovenous malformations and 
other cerebrovascular diseases (Fabrikant et al., 1989, 1985, 1984; 
Kjellberg et al., 1983; Levy et al., 1989; Steinberg et al., 1990). 
In these studies, associations with neurological complications are 
found, such as impairments in cognitive function, language ac-
quisition, visual spatial ability, memory and executive function, 
as well as changes in social behaviors. Similar effects did not 
appear in patients treated with chemotherapy. In all of these ex-
amples the patients were treated with extremely high doses that 
were below the threshold for necrosis (Goldberg et al., 1982;
Keime-Guibert et al., 1998).
3.2. Studies of CNS risks in atomic-bomb survivors and radiation 
workers
More recently studies of possible CNS injury in adults after low 
to moderate doses of radiation (up to 2 Gy) have been consid-
ered in the A-bomb survivors (Yamada et al., 2009) and clean-
up workers at the Chernobyl accident (Bromet et al., 2011). In a 
study of 2200 survivors by Yamada et al. (2009) no association be-
tween increased risk of dementia in survivors and radiation dose 
was found. But this study is limited by several factors including 
the small subset of less than 3% of the survivors in the Japanese 
life-time study, the restriction to a small observational window 
many years after the exposure, and the diﬃculties in classifying 
early stages of dementia. Studies of the Chernobyl liquidator’s sug-
gests psychological effects have occurred years after the accident 
(Bromet et al., 2011). However these studies are confounded by the 
quality of the individual dosimetry, and the overall cultural stigma 
of the Chernobyl accident.
3.3. Limitations to studies in astronauts
The possible observation of CNS effects in astronauts partici-
pating in past NASA missions is highly unlikely. First, because the 
lengths of past missions are relatively short and the population 
size of astronauts is small. Secondly, in low Earth orbit (LEO) as-
tronauts are partially protected by the Earth’s magnetic ﬁeld and 
the solid body of the Earth, which together reduce the GCR dose-
rate by about 2/3 from its free space values. Furthermore, the 
GCR in LEO has lower LET components compared to the GCR to 
be encountered in transit to Mars or on the lunar surface because 
the Earth’s magnetic ﬁeld repels nuclei with energies below about 
1000 MeV/u, which are of higher LET. For these reasons, the CNS 
risks are of a higher concern for long-duration lunar missions or 
for a Mars mission than for missions on the International Space 
Station (ISS).
One area where direct observations of space radiation effects 
on astronauts has been demonstrated is the light ﬂashes that were 
observed by the astronauts during the early Apollo missions and 
dedicated experiments subsequently performed on later Apollo and 
Skylab missions (Pinsky et al., 1974). More recently, studies of light 
ﬂashes have been made on the Russian Mir space station and the 
International Space Station (ISS) (Sannita et al., 2004). A 1973 re-
port by the National Academy of Science discussed these effects 
in detail. This phenomenon, known as a phosphene, is the visual 
perception of ﬂickering light. It is considered a subjective sensa-
tion of light since it can be caused by simply applying pressure on 
the eyeball (NCRP, 2006). The traversal of a single highly charged 
particle through the occipital cortex or the retina was estimated 
to be able to cause a light ﬂash. Possible mechanisms for HZE-
induced light ﬂashes include direct ionization and Cerenkov ra-
diation within the retina. The observation of light ﬂashes by the 
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Limitations of rodent models and possible strength of NHP comparisons for human risk assessment.
Limitations in Rodents for investigating biological mechanisms and possible dose levels of concern for CNS space radiobiology:
• Drastically reduced numbers of neuron cells and synapses compared to humans or NHPs.
• Much higher levels of neurogenesis compared to humans or NHPs.
• Reduced axon size and number of synapses compared to humans and NHPs.
• Reduced pre-frontal cortex size and drastically reduced development of frontal lobe where higher cognition occurs (neocortex is 27% in rats, 72% in monkeys, 80% 
in humans).
• Performance and cognition tests limited compared to human abilities including inability to respond to visual cues.
• Manifestations of pathology of Alzheimer’s disease and other late effects extremely limited (partially reconstructed in transgenic mice/rats).
• Genetic overlap of the rodent CNS with human CNS is small (20% compared to >80% in NHP).
Attributes for use of NHPs for estimating GCR risks:
• High level of genetic overlap.
• Developed neocortex, including more similar levels of neurons, synapses, and rates of neurogenesis.
• NHPs have forward-facing eyes and complex visual behavior, which is not found in rodents.
• NHPs have been shown to contain mirror neurons in the pre-frontal cortex that are speciﬁc to a particular action, and part of a brain network. Mirror neurons are 
not believed to exist in rodents.
• NHPs develop plaques and other pathological lesions observed in Alzheimer’s or Parkinson’s diseases.
• NHP share many common features related to memory and cognition with humans that are not found in rodent research models.
• NHPs can be trained for identical cognitive testing including responding to visual cues that are used in human studies making translation of results immediately 
analyzable.astronauts helped bring attention to the possible effects of HZE 
nuclei on brain function (NAS, 1973).
3.4. Non-human primates
Non-human primates (NHP) and humans are quite similar in 
their genetic, physiological, pharmacokinetic, and neurobiological 
characteristics while there are a large number of important dif-
ferences between rodents and humans (Weatherall, 2006; Dorus 
et al., 2004; Heekren et al., 2008). Non-human primates are used 
widely for speciﬁc areas of research including HIV/AIDS and in-
fectious diseases, and neuroscience research (reviewed by the 
Weatherall Report 2006). Research on drug addiction, Parkinson’s 
disease, Alzheimer’s disease and stroke includes the use of NHP is 
being pursued in the U.S. and many other countries. Because of 
cross-species differences between humans and rodents, the deter-
mination of clinical signiﬁcance for CNS health risks remains an 
important problem, especially if based on studies in rodents alone. 
This important issue is compounded for CNS cognitive risks which 
are known to originate in the frontal cortex, which is highly un-
der developed in rodents compared to humans although rodents 
do provide some indication of cognitive risks related in the frontal 
cortex (Davis et al., 2014; Lonart et al., 2012). A well-known ex-
ample in inter-species differences in risk assessment is the dose 
for acute death for 50% of a population from low LET radiation 
exposure occurs at 3.5 Gy for humans and non-human primates, 
while is as high as 7 Gy for various species or strains of rodents. 
At this time it is not clear if humans would be more or less sen-
sitive to CNS risks compared to observations in rodent models. In 
broad-terms, mice and rats are used to investigate biological mech-
anisms and possible dose levels of concern, however are limited 
in representing human risks due to biological differences as sum-
marized in Table 2. However, NHP research requires much higher 
costs, and extra-levels of review and expanded ethical consider-
ations before being considered. It is important that such studies 
be preceded with extensive research in cell and rodent models in 
order to ﬁrst indicate if potential CNS risks are possible. Consider-
ations of the feasibility of deep space missions and time-lines for 
missions planning relative to research maturity are also needed.
In the mid-1960s, the U.S. Air Force and NASA supported ex-
periments that studied acute and late radiation risks from X-rays
and protons of irradiated Rhesus monkeys (reviewed in Dalrymple 
et al., 1991; Wood, 1991; Lett et al., 1991). Several proton accel-
erators in the U.S., including Brookhaven National Lab, were used 
to study a wide spectrum of proton energies in these studies. Sub-
groups of the cohorts were followed to study cancer and cataract 
risks. The study ended in the early 1990s when the last monkeys died. The results proved to be critical in preparing for the Apollo 
missions because the biological effects of solar protons that where 
largely unknown at the time, and provided important information 
on the risks associated with acute effects, and late on cataract and 
cancer formation from radiation exposure involving solar protons 
(NCRP, 1989). No studies on CNS effects were made with mon-
keys that were irradiated largely with high doses of X-rays or 
protons (>1 Gy). However balloon-borne rhesus monkeys were ex-
amined for CNS lesions after short-duration ﬂights (Haymaker et 
al., 1970).
4. Behavioral studies of CNS risks
As noted above a major difference between CNS effects and 
cancer risk assessments is the lack of a human data set such as the 
epidemiology studies of the atomic-bomb survivors, which could 
be combined with RBE factors determined experimentally to pre-
dict CNS risks in astronauts from speciﬁc space mission. A second 
major difference is the observation of endpoints measured in ex-
perimental models that directly reﬂects the risk to humans. Behav-
ioral tests in mice and rats are a major focus of space CNS radio-
biology, however the extrapolation of these results to humans has 
not been established. We review these studies next with a focus 
on the understanding dependencies on dose, particle type or LET, 
sex, age at exposure and time after exposure. In Table 3 we show 
a snapshot of these studies that illustrates the variety of tests uti-
lized in different studies, including areas of the brain considered, 
the types of radiation and doses used, and whether signiﬁcant dif-
ferences were observed. A large number of behavior tests have 
been considered in mice and rats that indicate signiﬁcant deﬁcits 
will occur at doses of 0.5 Gy and higher of HZE particles, and po-
tential detriments at lower doses. Only a few particle species have 
been used in report to date with Fe, H and Si most frequent and 
many fewer studies with other GCR nuclei. No studies have been 
made for a chronic exposure or for the mixed radiation ﬁeld that 
occurs in space. Brain areas indicated to lead to cognitive detri-
ments in these studies include the striatum, hippocampus, and the 
pre-frontal cortex.
Sensorimotor deﬁcits and neurochemical changes were ob-
served in rats exposed to low doses of 56Fe (Joseph et al., 1992, 
1993). Doses below 1 Gy reduced performance, as tested by the 
wire suspension test. Behavioral changes were observed as early 
as 3 days after radiation exposure and lasted up to 8 months. Bio-
chemical studies showed that the K+-evoked release of dopamine 
was signiﬁcantly reduced in the irradiated group, along with al-
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Hippocampal 
dependent memory
Britten et al. (2012)
Hippocampal 
dependent memory
Britten et al. (2012)
Pre-frontal cortex 
(executive function)
Lonart et al. (2012)
 Midbrain dopamine 
function
Joseph et al. (1992)
 Midbrain dopamine 
function
Rice et al. (2009)
Midbrain dopamine 
function
Shukitt-Hale et al. (2004)
Midbrain dopamine 
function
Rabin et al. (2011)
Midbrain dopamine 
function
Rabin et al. (2011)
Midbrain dopamine 
function
Rice et al. (2009)
 Midbrain dopamine 
function
Rabin et al. (2005)Table 3
Summary of representative results from mouse and rat studies with HZE particles on changes to behavior and cognition.
Test Animal model (sex) Age at IR, 
m
Timepoint post IR, 
m
Particle Doses, Gy Signiﬁcant result
Open-ﬁeld, rotorod, acoustic
startle
Mice, C57Bl (F) ∼3 0.5–2 56Fe (1000 MeV/u) 0.1, 0.5, 2 None
Contextual freezing and
spatial memory
Mice, C57Bl/6J (M) ∼3 0.5 56Fe (600 MeV/u) 0.1, 0.2, 0.5 None
Novel object recognition Mice, C57Bl/6J (M) ∼3 0.5 56Fe (600 MeV/u) 0.1, 0.2, 0.5 0.1, 0.2, 0.5 Gy
Contextual freezing Mice, C57Bl/6J (M) ∼3 3 28Si(600 MeV/u) 0.25, 1.0 0.25 Gy
Contextual freezing Mice, APP/PS1 Transgenics (M) ∼3 9.5 56Fe (1000 MeV/u) 0.1, 1.0 1.0 Gy
Novel object recognition Mice, APP/PS1 Transgenics (M) ∼3 9.5 56Fe (1000 MeV/u) 0.1, 1.0 0.1, 1.0 Gy
Cued tone response Mice, APP/PS1 Transgenics (M) ∼3 9.5 56Fe (1000 MeV/u) 0.1, 1.0 None
Contextual freezing Mice, APP/PS1 Transgenics (F) ∼3 7 56Fe (1000 MeV/u) 1 None
Novel object recognition Mice, APP/PS1 Transgenics (F) ∼3 7 56Fe (1000 MeV/u) 1 1.0 Gy
Cued tone response Mice, APP/PS1 Transgenics (F) ∼3 7 56Fe (1000 MeV/u) 1 None
Relative escape latency Rats, Wistar (M) ∼2 3 56Fe (1000 MeV/u) 0.2, 0.4, 0.6 All doses signiﬁcant
Relative escape latency Rats, Wistar (M) ∼2 3 X-rays 8, 10, 13 13 Gy
Attentional set-shifting Rats, Wistar (M) ∼2 3 56Fe (1000 MeV/u) 0.2 0.2 Gy




Rats, Sprague-Dawley (M) ∼2 3, 6, 10, 12 56Fe (1000 MeV/u) 1.2, 2.4 3 m no, 6 m yes, 12 m
only at 2.4 Gy
Conditional Taste Aversion 
(CTA), Morris Water Maze 
(MWM)
Rats, Sprague-Dawley (M) 2 up to 3 m Protons (250 MeV) 1.5, 3, 4 None
Operant-conditioning Rats, Sprague-Dawley (M) ∼2 3, 6, 10, 12 28Si(1000 MeV/u) 0.5, 0.8, 1.0 1.0 Gy
Operant-conditioning Rats, Sprague-Dawley (M) ∼2 3, 6, 10, 12 48Ti (1100 MeV/u) 0.25, 0.5, 1.0 0.5, 1.0 Gy
Operant-conditioning Rats, Sprague-Dawley (M) ∼2 3, 6, 10, 12 56Fe (1000 MeV/u) 1.2, 2.4 No
Operant-conditioning Rats, Sprague-Dawley (M) 2 3, 7, 11, 15 56Fe (1000 MeV/u) 1, 1.5, 2 At 2 m, 2 Gy. At 7, 11,
15 all doses
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havioral deﬁcits observed in female C57/BL6 mice in a 2 to 8 week 
period following exposure to 0, 0.1, 0.5 or 2 Gy accelerated iron 
ions (1000 MeV/u 56Fe) using open-ﬁeld, rotorod, or acoustic star-
tle habituation tests.
There is evidence that deﬁcits in conditioned taste aversion 
(CTA) are induced by low doses of heavy ions (Hunt et al., 1989; 
Rabin et al., 1989, 1991, 2000a, 2000b, 2003). The CTA test is a 
classical conditioning paradigm that assesses avoidance behavior 
that occurs when ingestion of a normally acceptable food item 
is associated with illness. This is considered a standard behav-
ioral test of drug toxicity (Riley and Tuck, 1985). The dopamin-
ergic system was associated with radiation-induced changes in 
CTA, whereby amphetamine-induced CTA, which depends on the 
dopaminergic system, was affected by radiation, whereas lithium 
chloride-induced CTA, which does not involve the dopaminergic 
system, is not affected by radiation. It was established that the 
degree of CTA due to radiation was LET-dependent and that 56Fe 
particles are the most effective among the various low and high 
LET radiation types that have been tested (Rabin et al., 1989, 1991). 
Acute doses as low as 0.2 Gy of 56Fe ions appear to have an effect 
on CTA in these studies.
The relative effectiveness and threshold doses of different types 
of heavy particles on cognitive/behavioral performance were in-
vestigated in Sprague–Dawley rats (Rabin et al., 2007b, 2011). The 
relationship between radiation quality and possible thresholds was 
studied for the HZE particle-induced disruption of amphetamine-
induced CTA learning. A similar pattern of responsiveness to the 
disruptive effects of exposure to either 56Fe or 28Si particles on 
both CTA learning and operant responding. Lower dose thresholds 
were found for 16O of lower LET compared to heavier particles of 
higher LET (Rabin et al., 2011). These results suggested that the 
effectiveness of different particles for neurobehavioral dysfunction 
is not predicted solely on the basis of the linear energy transfer 
of the speciﬁc particle. The threshold doses for these effects are 
above the annual GCR dose in free space for some but not all parti-
cle types. However, how such effects would extrapolate to humans 
and the potential for any CNS repair in a chronic exposure are not 
understood to make any conclusions on thresholds for long-term 
space missions.
Operant conditioning utilizes several consequences to modify 
a voluntary behavior. Studies by Rabin and colleagues (Rabin et 
al., 2003) have examined the ability of rats to perform an operant 
order to obtain food reinforcement using an ascending ﬁxed-ratio 
schedule (FR). They found that 56Fe doses above 2 Gy affect the ap-
propriate responses to increasing work requirements. For tests 13 
and 18 months after irradiation, Rabin et al. (2003) did not observe 
differences in performance between the irradiated rats maintained 
on control, strawberry or blueberry diets, suggesting the beneﬁcial 
effects of antioxidant diets may be age dependent. Studies on rats 
were performed using the Morris water maze test 1 month after 
whole-body irradiation with 1.5 Gy of 56Fe (1000 MeV/u) parti-
cles. Irradiated rats demonstrated cognitive impairment compared 
to the controls that were similar to those seen in aged rats. This 
leads to the possibility that an increase in the amount of ROS may 
be responsible for the induction of both radiation- and age-related 
cognitive deﬁcits (Shukitt-Hale et al., 2000, 2003).
Denisova et al. (2002) exposed rats to 1.5 Gy of 56Fe particles 
(1000 MeV/u) and tested their spatial memory in an eight-arm 
radial maze. Cognitive behavior deﬁcits were observed, including 
exposed rats committing more errors than control rats in the ra-
dial maze and they were unable to adopt a spatial strategy to solve 
the maze (Denisova et al., 2002). Studies were made to identify 
speciﬁc brain-region alterations in relationship to sensitivity to ox-
idative stress, inﬂammation or neuronal plasticity. The striatum, 
hippocampus and frontal cortex from exposed rats were isolated Fig. 2. Brain-region-speciﬁc calcium-dependent protein kinase C expression was 
assessed in control and irradiated rats using standard Western blotting proce-
dures. Values are means ± SEM (statistical errors of the means) (reproduced from 
Denisova et al., 2002).
and compared to controls. Irradiated rats were adversely affected 
as reﬂected through the levels of dichloroﬂuorescein, heat shock, 
and synaptic proteins (for example, synaptobrevin and synapto-
physin). Changes in these factors consequently altered cellular sig-
naling (for example, calcium-dependent protein kinase C and pro-
tein kinase A), with signiﬁcant correlations found with working 
memory errors in the radial maze. The results show differential 
brain-region-speciﬁc sensitivity induced by 56Fe irradiation (Fig. 2). 
Radiation signiﬁcantly attenuated the expression of hippocampal 
calcium-dependent PRKCs, however striatal and cortical calcium-
dependent PRKC expression was not affected.
Raber’s lab (Haley et al., 2013) studied the effects of 56Fe irra-
diation on hippocampal function starting two weeks after whole-
body irradiation. Compared to sham irradiation, radiation impaired 
novel object recognition and spatial memory retention in female 
and male C57BL/6J wild-type mice. There were no effects of ir-
radiation on contextual fear conditioning or spatial memory re-
tention in the water maze. These results are of major importance 
because they demonstrate detriments at an early time point for 
doses as low as 0.1 Gy. Since oxidative damage could contribute 
to radiation-induced cognitive changes, hippocampal and cortical 
levels of 3-nitrotyrosine (3NT) and lipid peroxidation, measures of 
oxidative damage were assessed. There were no effects of irradi-
ation on these measures of oxidative damage. As 56Fe irradiation 
can increase reactive oxygen species (ROS) levels, which may con-
tribute to the impairments in novel object recognition, the effects 
of the antioxidant alpha-lipoic acid (ALA) on cognition following 
sham irradiation and irradiation were also assessed. ALA did not 
prevent radiation induced impairments in novel object recogni-
tion and impaired spatial memory retention of sham-irradiated 
and irradiated mice in the probe trial after the ﬁrst day of hid-
den platform training in the water maze. Other studies by Raber 
et al. have found signiﬁcant changes in contextual fear condition-
ing and spatial memory retention at later time points (3 months or 
longer). It is interesting to compare these differences at early and 
late time-points in relation to the kinetics of neurogenesis in the 
dentate gyrus where neuron integration occurs over several weeks. 
This suggests that damage to neural stem cells and supporting cells 
in the micro-environment may not manifest deﬁcits for more than 
1 month post-IR, especially at lower doses (<1 Gy).
The studies of Britten (Britten et al., 2010, 2012; Lonart et al., 
2012) has considered the possibility that neurocognitive tasks reg-
ulated by the prefrontal cortex could be impaired after exposure to 
low doses of HZE-particles, which could prevent astronauts from 
performing complex executive functions. They used male Wistar 
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3 months later for their ability to perform attentional set shift-
ing. Compared to the controls, rats that received 0.2 Gy of 56Fe 
(1000 MeV/u) particles showed signiﬁcant impairments in their 
ability to complete the attentional set-shifting test, with only 17% 
of irradiated rats completing all stages as opposed to 78% of the 
control rats. The majority of failures (60%) occurred at the ﬁrst 
reversal stage, and half of the remaining animals failed at the 
extra-dimensional shift phase of the studies. These observations 
suggest that exposure to mission relevant doses of 56Fe particles 
results in the loss of functionality in the pre-frontal cortex, how-
ever further investigation is needed to identify other brain regions, 
including the anterior and posterior cingulated cortex and basal 
forebrain that are possibly impacted by space radiation exposure. 
Further studies with other HZE particles at doses below 0.1 Gy, 
and chronic or fractionated doses up to cumulative doses of 0.1 to 
0.2 Gy are suggested as a continuation of these studies.
5. Biomarker and mechanistic studies of CNS risks
An extensive number of biomarker and mechanistic studies 
have been reported using cell culture or rodent models. Experi-
ments have considered various types of neurons, neuronal stem 
cells (Fike et al., 2009), microglial cells and astrocytes. Indicators 
of damage include reactive oxygen or nitric-oxide species, and var-
ious studies on signaling molecules. Several studies have focused 
on alterations in neurogenesis and neuroinﬂammation. More re-
cent studies have used transgenic mice to study AD pathology and 
related AD biomarkers including amyloid-beta (Aβ), tau-protein, 
changes in long-term potentiation (LTP) and alterations in den-
dritic morphology. Other studies have considered serum biomark-
ers (Britten et al., 2010), gene arrays (Lowe and Wyrobek, 2012;
Shukitt-Hale et al., 2013) and micro-RNA (Shi et al., 2012). The 
brain (micro)vasculature which exhibits a comparable vulnerabil-
ity for radiation damage to that found elsewhere in the body 
(Reinhold and Hopewell, 1980) has also been studied (Mao et 
al., 2010). Radiation-induced damage to oligodendrocytes and en-
dothelial cells of the vasculature accounts for major aspects of the 
pathogenesis of brain damage that can occur after high doses of 
low-LET radiation (Schultheiss et al., 1995) and should be consid-
ered for high LET radiation (NCRP, 2006).
5.1. Cell loss, apoptosis and autophagy
An early theme in CNS space radiobiology was experiments 
considering neuronal cell loss after HZE particle exposure (NAS, 
1973; Philpott et al., 1985). Two to three weeks following doses of 
0.1, 1 and 10 Gy of 400 MeV/u 20Ne particles slowed to an energy 
of 40 MeV/u with an absorber, the percentage of necrotic cells in 
the cerebrum of pocket mice was <0.0005, 0.003, and 0.04%, and 
smaller number in other brain areas studied (Kraft et al., 1979). 
Slightly larger changes but insigniﬁcant losses were observed in 
the cerebrum and dentate gyrus within 1 day of exposure. Stud-
ies by Williams and Lett (1994, 1996) considered photoreceptor 
cell loss through what was likely apoptosis at different time points 
in New Zealand White rabbits following doses of 0.5 to 3.5 Gy 
of 56Fe (600 MeV/u). Photo-receptor losses approaching 10% were 
observed by 20 month post-exposure to 2.88 Gy of 56Fe. Similar 
losses were not observed at long post-exposure times using γ -rays, 
Ne or Ar particle beams. Extrapolation of these results to space rel-
evant doses of HZE particles (0.1 Gy or less) suggests immediate or 
delayed loss of neurons should not play a signiﬁcant role for space-
ﬂight.
In a series of studies over many years, Rabin and co-workers 
have shown that even though exposure to HZE particles occurs 
at low ﬂuence rates, HZE exposure result in molecular changes similar to those seen in aged animals (Rabin et al., 2003, 2007a, 
2012). More recently Poulose et al. (2011) assessed markers of 
autophagy, a dynamic process for intracellular degradation and 
recycling of toxic proteins and organelles, and stress and inﬂam-
matory responses, in the brains of Sprague-Dawley rats irradiated 
at 2 months of age with 0.05, 0.5 and 1 Gy of 16O particles 
(1000 MeV/u). Results showed that compared to non-irradiated 
controls, 16O particles signiﬁcantly inhibited autophagy function 
in the hippocampus as measured by accumulation of ubiqui-
tin inclusion bodies such as P62/SQSTM1, autophagosome marker 
microtubule-associated protein 1 beta light chain 3 (MAP1B-LC3), 
beclin1 and proteins such as mammalian target of rapamycin 
(mTOR). For both short (36 h) and long (75 days) intervals ex-
posure, molecular markers indicated that the loss of autophagy 
function occurred shortly after exposure but was recovered via 
inhibition of mTOR. Poulose et al. (2011) also looked at correla-
tions in levels of protein kinase C alpha (PKC-a), a key G protein 
modulator involved in neuronal survival and functions of neuronal 
trophic factors, nuclear factor kappa B (NF-κb) and glial ﬁbrillary 
acidic protein (GFAP), indicating glial cell activation 75 days after 
exposure. Overall their ﬁndings detail the molecular effects of 16O-
particle radiation as they relate to early and late oxidative stress, 
inﬂammation and loss of autophagy in rat brains.
5.2. Altered neurogenesis
In recent years, studies with stem cells uncovered that neu-
rogenesis still occurs in the adult dentate gyrus subventricular 
zone (SVZ) and the subgranular zone (SGZ). Speciﬁc hippocampal-
dependent cognitive impairment such as memory and learning 
are being considered in terms of changes to neurogenesis (Squire, 
1992; Eisch, 2002; Rola et al., 2004; Raber et al., 2004). Studies of 
neurogenesis have provided an approach to understand mechanis-
tically some of the factors that affect hippocampal risk from space 
radiation exposure. Accumulating data indicates that radiation not 
only affects differentiated neural cells but also proliferation and 
differentiation of neuronal precursor cells, and even adult stem 
cells. Recent evidence points out that neuronal progenitor cells are 
sensitive to radiation (Mizumatsu et al., 2003; Monje et al., 2002;
Toﬁlon and Fike, 2000). Acharya et al. (2011) showed that human 
neural stem cell transplantation ameliorates radiation-induced cog-
nitive dysfunction in mice following radiation exposure. Studies on 
low-LET radiation showed that high dose radiation stops not only 
the generation of neuronal progenitor cells, but also their differ-
entiation into neurons and other neural cells. Cells in the dentate 
SGZ undergo dose-dependent apoptosis above 2 Gy of X-ray irradi-
ation. The production of new neurons in young adult male mice 
is signiﬁcantly reduced by relatively doses of 2 Gy or more of 
X-rays. Measurements of activated microglia indicated that changes 
in neurogenesis were associated with a signiﬁcant dose-dependent 
inﬂammatory response even 2 months after irradiation. This work 
suggests that the pathogenesis of radiation-induced cognitive in-
jury may involve loss of neural precursor cells from the SGZ of the 
hippocampal dentate gyrus and alterations in neurogenesis.
Studies of altered neurogenesis in the SGZ after radiation ex-
posure using HZE nuclei were considered in rats by Casadesus et 
al. (2004, 2005) and in mice by Rola et al. (2004, 2005, 2008)
and more recently by Riviera et al. (2014). Casadesus et al. (2005)
demonstrated that HZE radiation led to progressive loss of neu-
ronal progenitor cells in the SGZ at doses of 1 to 3 Gy of 56Fe 
(1000 MeV/u) in a dose-dependent manner. These results indicate 
that high-LET radiation has a signiﬁcant and long-lasting effect on 
the neurogenic population in the rat hippocampus that involves 
cell loss and changes in the microenvironment. Rola et al. (2008)
quantiﬁed neurogenesis and activated microglial as an indicator 
or neurogenesis at two months post-IR using doses of 0.5–4.0 Gy 
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0.5 Gy, which is potentially an important result for understand-
ing GCR risks to the CNS because HZE particle mission doses are 
not expected to exceed 0.1 Gy. However it will be important to ex-
tend these studies to longer post-irradiation times and for lower 
particle doses with adequate sample sizes. Riviera et al. (2014)
compared acute exposures of 1 Gy to 5 × 0.2 Gy fractions of 56Fe 
(1000 MeV/u) in 1-day intervals using transgenic mice which were 
inducible to allow cell tracking. They found few signiﬁcant differ-
ences between acute and fractionate exposures. These studies are 
at dose-rates much higher than in deep space (∼0.5 mGy/d at so-
lar minimum), however are the ﬁrst to consider fractionation to 
study CNS effects with HZE particles.
5.3. Neuroinﬂammation
Neuroinﬂammation has been recognized as a major factor as-
sociated with neurodegenerative diseases, such as AD and Parkin-
son’s disease (PD) (Glass et al., 2010). Neuroinﬂammation is a fun-
damental reaction to brain injury, characterized by activation of 
resident microglia and astrocytes and local expression of a wide 
range of inﬂammatory mediators. ROS are key signaling molecules 
in the inﬂammatory response and therefore considered as a key 
contributor in neurodegenerative diseases. Increasing production of 
ROS, such as post IR exposure, can regulate the expression of di-
verse inﬂammatory mediators during brain injury, resulting in the 
damage or death of parenchymal cells in the brain. The fact that 
moderate or high doses of high LET particles produce signiﬁcantly 
higher level of ROS compared to similar doses of low LET radiation 
denotes the potential initiation and ampliﬁcation effects of space 
radiation on neuroinﬂammation and neurodegenerative diseases, 
however effects at space relevant doses have not been observed.
Studies that followed whole-brain radiotherapy in children 
demonstrated a late side effect of radiation somnolence syn-
drome (RSS), in which an inﬂammatory response has been con-
sidered as a key player (Ballesteros-Zebadúa et al., 2012). Pro-
inﬂammatory cytokines such as interleukin-1β , tumor necrosis 
factor-α, interleukin-6 and interleukin-18 were found in the brain 
post low LET radiation. COX-2 pathways are implicated in neu-
roinﬂammatory processes caused by low-LET radiation. COX-2 up 
regulation in irradiated microglia cells leads to prostaglandin E2 
production, which appears to be responsible for radiation induced 
gliosis (over proliferation of astrocytes in damaged areas of CNS) 
(Kyrkanides et al., 2002; Moore et al., 2005; Hwang et al., 2006). 
Other inﬂammatory markers such as GFAP, intercellular adhesion 
molecule-1 and NF-κb are also found involved in the brain re-
sponse to radiation (Ballesteros-Zebadúa et al., 2012).
Human data on HZE particles radiation are lacking, but acute 
and chronic neuroinﬂammation has been studied in the mouse 
brain following exposure to HZE particles. The estimated RBE value 
of HZE irradiation is 3 compared to gamma irradiation, for induc-
tion of an acute neuroinﬂammatory response (Rola et al., 2005). 
Increased expression of the CCR2 receptor in the subgranular zone 
9 months after 1–3 Gy 12C or 56Fe irradiation (Rola et al., 2005). 
However, studies published to date (Rola et al., 2008; Cherry et al., 
2012) do not indicate a signiﬁcant induction of neuroinﬂammation 
at lower HZE particle doses (0.1 to 0.5 Gy). It will be important 
to extend these studies to other particle types, chronic exposures 
of several weeks, and for space mission relevant organ doses from 
0.05 to 0.2 Gy.
5.4. Oxidative and radical damage
Oxidative damage is one of the main inducers of CNS detri-
ments. In vitro and in vivo experiments have been performed both showing ROS at higher doses, while in vitro experiments have re-
ported direct observation of ROS at low acute HZE doses (<0.5 Gy). 
Adult rat neural precursor cells from the hippocampus show an 
acute dose-dependent apoptotic response that was accompanied 
by an increase in ROS (Limoli et al., 2004, 2007). Giedzinski et al.
(2005) reported that relative ROS levels were increased for doses 
of 1 to 10 Gy of Bragg-peak 250 MeV protons at post-irradiation 
times (6 to 24 hours) compared to unirradiated controls. The in-
crease in ROS after proton irradiation was more rapid than that 
observed with X-rays and showed a signiﬁcant dose response at 6 
and 24 hours, increasing about 10-fold at a rate of 3% per Gy. At 
48 hours post irradiation, ROS levels fell below controls and coin-
cided with minor reductions in mitochondrial content. Use of the 
antioxidant alpha-lipoic acid (ALA) (before or after irradiation) was 
shown to eliminate the radiation-induced rise in ROS levels. High 
LET radiation led to signiﬁcantly higher levels of oxidative stress 
in hippocampal precursor cells when compared to low LET (X-rays
or protons). The use of ALA was able to reduce ROS levels below 
background levels when added before or after 56Fe particle irradi-
ation.
Using the DCF-associative ﬂuorescence measure of oxidative 
stress, Denisova et al. (2002) considered possible increases in ox-
idative stress in the striatum, hippocampus and frontal cortex of 
2 month old Sprague-Dawley rats at 5 weeks post irradiation of 
1.5 Gy of 56Fe (1000 MeV/u). For this time-point and dose, only 
the frontal cortex showed an increase in oxidative stress. However, 
there was no correlation of DCF levels in frontal cortex with tests 
of reference memory in the same animals. Suman et al. (2013)
used ﬂow cytometry to compare increases in ROS in the cerebral 
cortex of C57BL/6J female mice from 1.6 Gy of 56Fe (1000 MeV/u) 
to 2.0 Gy of gamma-rays at 2 and 12 months post-IR. A signiﬁcant 
increase was observed for both time points for 56Fe exposures but 
not for gamma-rays. However, no studies were performed at space 
relevant HZE particle doses (0.1 Gy or less) or for chronic expo-
sures.
Several mechanistic studies of CNS injury have led to important 
insights into radiation effects. Because of the HZE induced ROS ob-
served in prior studies, Villasana et al. (2013b, 2013a) investigated 
the effects of the ALA on cognition following sham-irradiation and 
irradiation with 56Fe (600 MeV/u). In this study male mice were 
irradiated (brain only) for doses of 3 Gy or sham-irradiated at 6–9 
months of age. Half of the mice were fed a regular chow and the 
other half of the mice were fed a caloric-matched diet contain-
ing ALA starting two-weeks prior to irradiation and throughout 
cognitive testing. Levels of 3-nitrotyrosine (3NT), a marker of ox-
idative protein stress, and levels of microtubule-associated protein 
(MAP-2), a dendritic protein important for cognition, were assessed 
using immunohistochemistry and confocal microscopy. In sham-
irradiated mice, ALA treatment impaired cortical-dependent novel 
object recognition and amygdala-dependent cued fear condition-
ing. Interestingly ALA prevented radiation-induced impairments in 
spatial memory retention in the hippocampal and cortical depen-
dent water maze probe trials following reversal learning. In the 
hippocampal dentate gyrus of mice on regular diet, irradiated mice 
had higher levels of MAP-2 immunoreactivity than sham-irradiated 
mice. Villasana et al. (2013b) concluded that ALA might have dif-
ferential effects on the brain under normal physiological conditions 
and those involving environmental challenges such as cranial irra-
diation. However, these studies will need to be extended tolower 
doses (<0.1 Gy) since the importance of ROS and anti-oxidants 
may be differential at high and low doses.
Some but not all animal experimental studies suggest antioxi-
dant and anti-inﬂammation should be investigated as countermea-
sures for CNS risks from space radiation. Diets of blueberries and 
strawberries were shown to reduce CNS risks after heavy ion expo-
sure. Estimating the effects of diet and nutritional supplementation 
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the other hand the recent study from the Raber lab (Haley et al., 
2013) showed no protective effect from anti-oxidants in reducing 
early cognitive changes following doses of 0.1 to 1 Gy of Fe par-
ticles. These results suggest that high LET radiation especially at 
low to moderate doses is less dependent on early oxidative stress 
responses to cause illicit detrimental effects. Some recent exper-
iments suggest, at least for acute high-dose irradiation, that an 
eﬃcient radioprotection by dietary supplements can be achieved, 
even in case of exposure to high-LET radiation. Melatonin which 
has anti-oxidant properties was found to be protective in pre-
venting inhibition of neurogenesis (Manda et al., 2008a, 2008b) 
following high dose 56Fe (500 MeV/u) exposures of mice. There 
is additional evidence that dietary antioxidants (especially straw-
berries) can protect the CNS from the deleterious effects of high 
doses of HZE particles (Rabin et al., 2005, 2009). However, be-
cause the mechanisms of biological effects are likely different at 
low dose-rates compared to acute irradiation, new studies for pro-
tracted exposures would be needed to understand the potential 
beneﬁts of biological countermeasures.
Concerns about the potential detrimental effects of antioxidants 
were raised by a meta-study of the effects of antioxidant sup-
plements in the diet of normal subjects (Bjelakovic et al., 2007, 
see also Durante and Cucinotta, 2008). Bjelakovic et al. (2007) did 
not ﬁnd statistically signiﬁcant evidence that antioxidant supple-
ments have beneﬁcial effects on mortality. On the contrary, they 
concluded that β-carotene, vitamin A, and vitamin E seem to in-
crease the risk of death. Concerns include that antioxidants may 
allow rescue of cells that still sustain DNA mutations or altered 
genomic methylation patterns following radiation damage to DNA, 
which can result in genomic instability. Other concerns may occur 
for neurocognitive effects were a delicate balance of redox states 
is crucial.
5.5. Long-term potentiation (LTP)
Synaptic plasticity is the ability of a chemical synapses to 
change their strength. Long-term potentiation (LTP) refers to a 
long-lasting enhancement in signal transmission between two neu-
rons that results from stimulating them synchronously. It is one 
of several phenomena underlying synaptic plasticity. Memories are 
thought to be encoded by modiﬁcation of synaptic strength. Mea-
surements of LTP are used as a cellular model for information 
storage in the brain.
Vlkolinský et al. (2007) exposed C57BL/6J mice to 56Fe
(600 MeV/u) particles at doses of 0, 1, 2, and 4 Gy (brain only) 
and measured LTP one-month post-IR, including studies with 
the additional challenge of the peripheral immunological stres-
sor, lipopolysaccharide (LPS) injected 4 h before hippocampal brain 
slices were prepared. LTP was not changed at 1 Gy and reduced at 
2 Gy compared to controls without LPS injection. LTP was reduced 
at 0 and 1 Gy with the addition of LPS but was increased at 2 Gy. 
Additional studies Vlkolinský et al. (2008) were performed at later 
times (up to 12 months post-IR) and indicated that 2 Gy doses 
of 56Fe modiﬁed the hippocampal response to an immunological 
stressor, however only transient differences were seen at the dose 
of 1 Gy.
In a more recent study, Rudobeck et al. (2014) used 28Si 
(600 MeV/u) at acute doses of 0.25 and 1.0 Gy to test for changes 
in synaptic plasticity in hippocampal slices prepared from ventral 
hippocampus in male C57BL/6J mice. Signiﬁcant changes were ob-
served at 1 Gy but not at 0.25 Gy. However, in study by Raber 
et al. (2014) also using 28Si (600 MeV/u) at doses of 0.25 and 
1 Gy results were dependent on whether mice were naïve or pre-
viously exposed to cognitive testing. Here there was a signiﬁcant 
LTP enhancement at 0.25 and 1.0 Gy in naïve mice, while mice that were previously exposed to a contextual freezing test and ex-
posed to 0.25 Gy showed a further LTP enhancement compared 
to naïve mice exposed to 0.25 Gy, but not at 1.0 Gy. Raber et al.
(2014) note that astronauts will undergo psychological and phys-
ical stressors during spaceﬂight, which suggest the use of mice 
exposed to cognitive tests could better represent spaceﬂight con-
ditions. These experiments for 28Si and 56Fe suggest that there are 
complicated relationships between dose, particle type and individ-
ual differences related to psychological stressors and adaptation 
that could impact changes in LTP, and therefore will require fur-
ther investigation, especially at lower doses (0.01 to 0.2 Gy).
5.6. Modiﬁcations to dendritic morphology
Neuron cells contain a soma, which includes the cell nucleus, 
axon, and a dendritic tree, which includes thousands of dendritic 
spines. An axon arises from the soma at a site called the axon 
hillock and extends for a long distance, which can be as far as 1 
meter in humans. Dendrites are thin structures, also arisen from 
the soma, which can extend for hundreds of micrometres, while 
branching multiple times giving rise to a complex “dendritic tree”. 
Dendritic spines are the postsynaptic elements of synapses found 
on dendrite branches in neuronal cells of the mammalian brain.
Recently Parihar and Limoli (2013) and Parihar et al. (2014)
examined changes in dendritic morphology and plasticity in hip-
pocampal slices from mice following doses of 0.1 and 1 Gy of 
protons or 1 and 10 Gy or X-rays at 10 and 30 day post-irradiation. 
Signiﬁcant changes in the number of dendritic branches, branch 
points, and dendritic length were observed at 30 d post-IR in-
dicating reduction in dendritic complexity has occurred due to 
radiation damage. Dendritic spines can be classiﬁed as ﬁlopodia 
(emerging spines) or spines of varying sizes or shapes including 
immature long spines, and mature stubby and mushroom spines. 
Signiﬁcant decreases were observed in the number of ﬁlopodia 
and long spines for proton exposures of 0.1 and 1 Gy, but not 
in mushroom and stubby spines. These differences are consistent 
with the larger sizes of ﬁlopodia and long spines, which are in-
tersected by a larger number of radiation tracks, however a rela-
tionship to changes in neuron plasticity is more likely. Using older 
experimental methodologies, Brizee et al. (1980) observed changes 
in dendritic morphology following prenatal irradiation of squirrel 
monkeys with 2 Gy of X-rays, which suggests these newer results 
(Parihar et al., 2014) with more sophisticated imaging approaches 
would also reﬂect the changes to be observed in human neuronal 
cells exposed to space radiation. New results for HZE particles us-
ing the experimental methodologies are expected to be reported in 
the near future by Limoli’s lab.
Estimates of HZE particle traversals to the CNS have been made 
for neuronal soma using the LET approximation by Gauger et al.
(1986) and Curtis et al. (1998), and with the additional contribu-
tion from delta-rays by Cucinotta et al. (1998), however these pre-
dictions greatly under-estimate the number of GCR particles traver-
sals to axons or dendritic trees, or the effects of particle traversals 
on the neuron micro-environment. Estimates of ﬂuence rates in tis-
sues for different particle types are useful descriptive parameters 
of the physical environment and possible damage to the CNS. Ta-
ble 4 using the NSCR-2012 model (Cucinotta et al., 2013a) shows 
that number of particle hits per year for GCR particles of increas-
ing ionization power in different regions of the hippocampus under 
typical spacecraft shielding. Clearly a large number of hits from 
HZE particles to sensitive brain regions will occur behind typical 
shielding amounts.
Cross-sectional areas of soma are typically up to a few 100 μm2, 
which compares to cross-sectional areas of spines and the den-
dritic trees of neuron cells of approximately 10 and 4000 to more 
than 20,000 μm2, respectively. Similarly the cross sectional area of 
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The number of GCR particle hits in the CA1, CA2/3 and Dentate Gyrus calculated 
using the NSCR-2012 model for average solar minimum conditions behind average 
spacecraft shielding (10 g/cm2 of Aluminum). Integral ﬂuence for all particles or for 
particles with values of Z∗ 2/β2 (Z∗ is the effective charge number and β is the 
particle velocity relative to the speed of light) above that indicated are shown for 
different regions of the hippocampus (CA1, CA2/3, or Dentate Gyrus).
Fluence 
>Z∗ 2/β2
Hits per day Hits per year
CA1 CA2/3 Dentate Gyrus Dentate Gyrus
All GCR 3.4× 105 1.1× 105 6.2× 105 2.3× 108
>100 (Z > 10) 321 106 595 2.2× 105
>250 (Z > 14) 90 30 166 6.1× 104
>500 38 13 71 2.6× 104
>1000
(stopping ions)
16 5 30 1.1× 104
axons from individual neurons can be very large compared to the 
soma, and varies over several orders of magnitude due to their 
variable lengths (up to 1 m) and diameters (up to 20 microns). 
Calculations by Alp, Limoli, and Cucinotta (in preparation, 2014) 
shown in Fig. 4 describe in detail the unique patterns of energy 
depositions that occur within mouse granule neurons as simulated 
using the Neuromorph data-base (Parekh and Ascoli, 2013) and a 
Monte Carlo model or HZE particle tracks (Plante and Cucinotta, 
2008). HZE particles produce large energy deposition (>200 eV) in 
small volumes (<20 nm) of biomolecular scale that are not pos-
sible with low LET radiation for doses below a few 10’s of Gy 
(Cucinotta et al., 2000). Clearly, qualitative differences in energy 
deposition for different radiation qualities occur and will likely re-
sult in radiation quality dependent damage to synapses.
5.7. Acceleration of Alzheimer disease pathologies
Alzheimer’s disease leads to massive neuronal cell and synapse 
loss beginning in the enthorhinal cortex and hippocampus.
Amyloid-beta (Aβ) plaques, neuroﬁbrillary tangles (NFTs) which 
contain the hyper-phosphorylated form of the tau protein, and 
changes to dendritic morphology related to synapse loss are im-
portant biomarkers of AD (Gotz and Ittner, 2008). Mutations in 
the amyloid precursor protein (APP), presenilin 1 (PSEN1) and 
presenilin 2 (PSEN2), which are components of the proteolytic 
γ -secretase complex that along with β-secretase form the Aβ
complex, are common in familial cases of AD. Wild type mice ex-
press signiﬁcant levels of APP however human mutations leading 
to high levels of Aβ production are not observed. Other differ-
ences between mice and humans for genes important in AD occur, 
with the result that mice do not usually show AD related patholo-
gies. Transgenic mice expressing APP, PSEN1, PSEN2 and other 
AD related genes have been produced, which mimic the cogni-
tive changes associated with AD and AD related pathologies (Gotz 
and Ittner, 2008). Space radiobiology researchers have begun to 
use several different AD transgenic mouse models to study if HZE 
particle exposure leads to an early time course for cognitive detri-
ments and AD related pathologies.
Vlkolinsky et al. (2010) examined whether HZE particle radia-
tion accelerated the age-related neuronal dysfunction using trans-
genic mice overexpressing human amyloid precursor protein (APP). 
APP23 transgenic mice exhibit age-related behavioral abnormali-
ties and deﬁcits in synaptic transmission. 7-week-old male APP23 
transgenic mice were exposed to brain-only 56Fe-particle radia-
tion (600 MeV/u; 1, 2, 4 Gy) synaptic transmission in hippocampal 
slices were recorded at ages of 2, 6, 9, 14 and 18–24 months post-
irradiation, and stimulated Schaeffer collaterals and recorded ﬁeld 
excitatory postsynaptic potentials (fEPSP) and population spikes 
(PS) in CA1 neurons. Results showed that radiation accelerated the 
onset of age-related fEPSP decrements recorded at the PS threshold 
from 14 months of age to 9 months and reduced synaptic eﬃcacy. At 9 months, radiation also reduced PS amplitudes. At 6 months, 
they observed a temporary deﬁcit in paired-pulse inhibition of the 
PS at a dose of 2 Gy.
The lab of O’Banion examined the effects of 56Fe particle irra-
diation in an APP/PS1 mouse model of AD (Cherry et al., 2012). 
APP/PS1 mice show Alzheimer’s pathologies at an old age and the 
goal of the study was to see if low doses of space radiation accel-
erated the age of appearance of AD pathologies. At 6 months after 
exposure to 0.1 and 1.0 Gy 56Fe (1000 MeV/u) radiation, APP/PS1 
mice show decreased cognitive abilities measured by novel object 
recognition testsin male mice. Results for contextual fear condition 
tests for male mice were changed at 1.0 Gy and not signiﬁcantly 
different from controls at 0.1 Gy. For female mice only 1.0 Gy was 
used and a signiﬁcant change for novel object recognition but not 
contextual fear conditioning was found. Male mice showed accel-
eration of Aβ plaque pathology (Fig. 3). Increases were not due 
to higher levels of APP or increased cleavage as measured by lev-
els of the beta C-terminal fragment of APP. Additionally, no change 
were observed in microglial activation levels judging by CD68 and 
Iba-1 immunoreactivities in and around Aβ plaques or insulin de-
grading enzyme, which has been shown to degrade Aβ . Immuno-
histochemical analysis of ICAM-1 showed evidence of endothelial 
activation after 1 Gy irradiation in male mice, suggesting possible 
alterations in Aβ traﬃcking through the blood brain barrier as a 
possible cause of plaque increase.
5.8. Signaling and neuro-transmitter changes
The electrical and chemical signaling processes in the CNS, 
which are related to a variety of functions and processes present 
distinct modes for perturbations by radiation to occur. An early 
CNS space radiobiology studies (Hunt et al., 1990) showed deﬁcits 
in 3-methooxytyramine (3-MT), a metabolite that reﬂects dopamine 
releases in rats, occurred at 3 d and 6 m post-IR for high doses of 
56Fe (600 MeV/u). This study was followed by more extensive bio-
chemical studies of changes to dopameric neurons by Joseph et 
al. (1992, 1993, 1999) and Villalobos-Molina et al. (1994) using 
doses of 0.1 to 1 Gy of 56Fe. Oxotremorine K+-evoked release of 
dopamine from perifused striatal slices was found to be degraded 
from 3 d to 6 m post IR for doses as low as 0.1 Gy, and shown to 
be related to a loss of sensitivity of muscarinic receptors.
In contrast to the studies of Joseph et al., the laboratory of 
Gatley used microPET imaging (Rice et al., 2006, 2009) and stain-
ing of rat brain sections for tyrosine hydroxylase and found no 
changes in the midbrain dopamine system following doses of 1.2 
and 2.4 Gy of 56Fe (1000 MeV/u). More recently Davis et al. (2014)
used adult male Long-Evans rats exposed to doses of 0.25 to 2 Gy 
of 150 MeV protons, and found a correlation between deﬁcits in 
dopamine transporters and responses to attentional deﬁcit tests in 
individual rats.
Studies of glutamate transport in co-cultures of human neu-
rons and astrocytes cells were performed by Sanchez et al. (2009, 
2010) using doses from 0.1 to 2 Gy of protons (250 MeV), 
12C (290 MeV/u) or 56Fe (1000 MeV/u). Glutamate uptakes occurs 
through the astrocytic transporter. These studies show an expected 
reciprocal response in glutamate transport of neurons and astro-
cytes with increased uptake in neurons post-IR and decreases in 
astrocytes. In vivo studies using Wistar rats exposed to 0.6 Gy 
of 56Fe (1000 MeV/u) showed signiﬁcant reductions in the NR1, 
NR2A, and NR2B subunits of the glutameric NMDA receptor at 
90 d post-IR (Machida et al., 2010), however the authors suggested 
further studies would be needed to determine the impacts of these 
reductions on neurocognitive impairment found in the same ani-
mals.
Fike and co-workers have assessed the molecular distribution of 
the behaviorally induced immediate-early gene Arc (activity reg-
64 F.A. Cucinotta et al. / Life Sciences in Space Research 2 (2014) 54–69Fig. 3. Immunohistochemical staining for Congo red and 6E10 increases after 56Fe particle irradiation (reproduced from Cherry et al., 2012). (A, C) Representative images 
of half male brains stained for Congo red (A) or 6E10 (C) 6 months after 0 Gy or 1 Gy 56Fe particle radiation. Scale bar is 1 mm. (B, D) Quantitative measurement 
of percent plaque area assessed with Congo red (B) and 6E10 (D). In addition, total number of individual 6E10 positive plaques (E) and the average size of plaques 
(μm2) (F) was determined. Each dot represents a single animal measured as percent area of the cortex and hippocampus combined. Data was analyzed with Student’s
t-test for the females and one-way ANOVA with a Bonferroni post test for the males. Data displayed as mean ±SD, n = 8–14 animals per dose. ∗ P < .05, ∗∗ P < .01. 
http://dx.doi.org/10.1371/journal.pone.0053275.g002. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this 
article.)
Fig. 4. Model predictions of energy depositions from 56Fe (200 MeV/u) particle track energy deposition in mouse granule neurons (Alp, Limoli, Cucinotta, in preparation). 
(Panel A) Track structure of energy deposition in layer of 5 neuron cells. (Panel B) Energy deposition in dendritic tree of a single neuron showing the spectrum of energy 
deposited, e in 20 × 20 × 20 nm voxels with blue, e < 20 eV, yellow 20 < e < 100 eV, and red e > 100 eV. The diameter of dendritic branches are between ∼1.4–2 μm. The 
dendrites are digitized as green connected cylindrical segments with topological neuron data as archived at NeuroMorpho.org (see Parekh and Ascoli, 2013). The rendered 
volume in these ﬁgures are 80 ×70 ×43 μm3 with the neuron structures and particle tracks each represented by 20 ×20 ×20 nm3 voxels. (For interpretation of the references 
to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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which plays an important role in neuroplasticity and memory. An 
important hypothesis is that alterations to the dentate gyrus ob-
served after HZE particle exposure is related to expression levels 
of Arc (Raber et al., 2013). Using doses of 0.5 Gy and 1.0 Gy of 
56Fe (600 MeV/u), Raber et al. (2013) showed that there was a sig-
niﬁcant correlation between deﬁcits in tests for contextual freezing 
and the percentage of Arc-positive cells in the enclosed and free-
blade of the dentate gyrus 3-months post-IR, and suggested that 
the enclosed blade is more important for contextual freezing and 
the free blade for cued freezing.
5.9. Individual risk factors
Individual factors for CNS risks of potential importance are age, 
sex, genetic factors, prior radiation exposure, and previous head in-
jury such as concussion. The recent study noted above by Raber et 
al. (2014) suggests adaptation to psychological and physical stres-
sors in space may also lead to individual differences in early CNS 
responses. Carey et al. (2007) and Rabin et al. (2012) considered 
the effects of age using male Fischer-344 rats exposed to 0.25 to 
2 Gy of 56Fe (1000 MeV/u) at ages of 2, 7, 12 and 16 months 
and tested for DA levels, and spatial learning and memory tasks. 
The model of Casarett (Rubin and Casarett, 1968; Cox et al., 1983) 
would predict that latency would be reduced at older ages com-
pared to younger ages of exposure, which is supported by these 
studies. However, including the dependence of the time of per-
formance testing suggests a more complicated relationship may 
occur. Rabin et al. (2012) note that older animals show increased 
detriments compared to younger animals for plus-maze perfor-
mance (Rabin et al., 2007a) and amphetamine-induced taste aver-
sion learning (Carrihill-Knoll et al., 2005), however these tests can 
only be measured at a single time point. Rabin et al. (2012) stud-
ies of disruption of operant-responding, which allows for multiple 
testing at different times points of individual animals, suggests 
a complicated relationship between age at irradiation and age of 
testing occurs that requires further investigation.
The Apolipoprotein E (APOE) has been shown to be an impor-
tant and common factor in CNS responses that leads to differences 
between males and females. APOE controls the redistribution of 
lipids amongst cells and is expressed at high levels in the brain 
(Raber et al., 1998; Laskowitz and Vitek, 2007). For females, apoE4 
increases the risks of AD compared to apoE4, while apoE2 de-
creases AD risk. Studies have considered the effects of space radia-
tion for the major isoforms of apoE, which are encoded by distinct 
alleles (ε2, ε3, and ε4). The isoform apoE4 has been shown to in-
crease the risk of cognitive impairments, and to lower the age for 
Alzheimer’s disease. It is not known if the interaction of radiation 
sensitivity or other individual risks factors is the same for high 
and low LET radiation. Other isoforms of apoE confer higher risk 
for other diseases. People who carry at least one copy of the APOE 
ε4 allele are at increased risk for atherosclerosis, which is also sus-
pected to be a risk increased by radiation. People who carry two 
copies of the APOE ε2 allele are at risk for a condition known as 
hyper-lipoproteinemia type III. It will be extremely challenging to 
consider genetic factors in a multiple radiation risk paradigm. For 
female mice signiﬁcant effects of irradiation on exploratory activ-
ity or measures of anxiety for different apoE isoforms were not 
found (Villasana et al., 2013a). Villasana et al. (2006, 2008, 2010, 
2011, 2013a) have shown increased neurocognitive deﬁcits in fe-
male apoE4 mice following 56Fe exposure, and a dependence on 
apoE isoforms was shown in cognitive tests in mice two weeks 
post-IR with 56Fe at a dose of 0.5 Gy (Haley et al., 2012). For male 
mice of different apoE isoforms more modest effects on responses 
to 56Fe exposures were found (Villasana et al., 2006). Differences between male and female mice were also observed in the studies 
of Cherry et al. (2012) using the APP/PS1 mouse model of AD.
A recent study (Davis et al., 2014) used head only irradiation 
with doses of 0.25, 0.5, 1 and 2 Gy of 150 MeV protons of Long-
Evans rats of 10–12 weeks of age that were tested at 250 days 
post-IR for performance detriments using an analog of the hu-
man psychomotor vigilance test (PVT). Overall performance detri-
ments were minimal, however in a subgroup of rats performance 
detriments were observed for all doses that were correlated with 
deﬁcits in the levels of the dopamine transporter and to a lesser 
extent the D2 receptor (Davis et al., 2014). These studies point to 
individual variations in CNS responses to radiation and elucidating 
individual differences will be important to be pursued in future 
research studies.
6. Synergistic risks in spaceﬂight
Space travel confers several other challenges to the CNS besides 
radiation exposure. These include microgravity, altered circadian 
rhythm that can lead to sleep deprivation, and challenges related 
to isolation and conﬁnement, as well as individual responses to 
psycho-social interactions (Benke et al., 1993; Dijk et al., 2001;
Gundel et al., 1997). Each of these challenges present new possi-
bilities for synergistic interactions leading to changes to cognition, 
including learning and memory that are being investigated due to 
space radiation exposures. Important areas of investigation are the 
role of cumulative radiation exposures where detrimental effect 
may only occur above a dose threshold, and how such thresh-
olds might be modiﬁed by synergistic factors. The use of phar-
maceuticals for sleep deprivation or other reasons could lead to 
short-term modiﬁcations of neurogenesis (Eisch, 2002), dopamine 
regulation or other neuronal pathways that are also impacted by 
space radiation. Also combined CNS challenges may lead to dis-
tinct assessments of individual sensitivity and the effectiveness of 
a countermeasure.
7. Conclusions
At this time, reliable projections for CNS risks from space radia-
tion exposure cannot be made due to a paucity of data for particles 
types, doses and dose-rates, and lack of understanding on the ex-
trapolation of experimental results with rodents to humans. The 
existing animal and cellular data suggest that space radiation can 
produce neurological and behavioral effects, and therefore the pos-
sibility exists for impacts for a Mars mission or other long duration 
deep space missions. However possible dose thresholds for these 
effects, and the signiﬁcance of these results on the morbidity to as-
tronauts has not been elucidated. It is to be noted that the studies 
to date have been carried out with relatively small numbers of an-
imals (typically <10 per dose group), and therefore testing of dose 
threshold effects at lower doses (HZE particle doses of <0.1 Gy/y 
and total GCR doses of <0.2 Gy/y) that would occur on space mis-
sions has not been carried out to a suﬃcient extent at this time 
and will require much large group sizes. Furthermore, studies with 
relatively few GCR species and at energies above 1000 MeV/u have 
not been made, nor studies with mixed ﬁelds of protons, neutrons, 
and HZE particles. The role of dose protraction has not been stud-
ied to any signiﬁcant detail. The NASA Space Radiation Lab (NSRL) 
is limited to energies of 1000 MeV/u and lower, while 50% or more 
of the GCR HZE particle ﬂuence in tissue is for particles with en-
ergies above 1500 MeV/u, which would be predicted to be less 
effective compared to lower energy particles (<1000 MeV/u) of 
similar LET (Cucinotta et al., 2013a).
The majority of CNS studies have been carried out at doses 
of 0.5 Gy or more, while many of these studies suggest a lack 
of signiﬁcant effects. However the studies of Rabin et al. (2011)
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et al. (2012) considering changes to executive function, Haley et 
al. (2013) on early cognitive changes, Limoli’s lab investigating 
changes to dendritic morphology (Parihar et al., 2014), and by 
Cherry et al. (2012) considering AD related pathologies, indicate 
signiﬁcant effects for acute HZE particle or proton doses as low 
as 0.1 Gy could occur. Certainly studies with a variety of HZE 
particles, simulating chronic radiation conditions, and for longer 
follow-up times are vitally needed in addition to the results re-
ported to date.
Because of the uncertainty in extrapolating dose thresholds 
from rodents to humans, we estimate that if a dose threshold two-
times higher than the expected HZE particle dose for a Mars mis-
sion near solar minimum were established it would ensure safety 
of crew for a Mars mission with additional considerations of the 
effects of low LET GCR and SPE exposures. However current data 
is uncertain as to a threshold dose for clinically signiﬁcant CNS 
effects, with estimates as high as 0.5 Gy to as low as 0.1 Gy of 
HZE particles possible. Reducing the uncertainty in this assumption 
through space radiobiology research would likely lead to a signif-
icant costs savings for space missions due to the possible mission 
impacts of an acute CNS risk limit with large uncertainty. A dose 
threshold of 0.2 Gy of HZE particles or higher would ensure that no 
signiﬁcant in-mission CNS effects to Mars mission’s crews would 
occur. Shielding would be an eﬃcient countermeasure to higher 
doses from SPEs. Additional considerations are needed to limit pos-
sible late effects, which should be included in life-time REID limits 
(Cucinotta et al., 2013a, 2013b; Cucinotta, 2014).
In considering a long term research strategy to quantitatively 
assess CNS risk from space radiation exposure, the following steps 
are recommended:
1) Establish the most important pathological processes and be-
havioral tests relevant to human risk using acute low dose 
radiation in rodents (0.01 to 0.5 Gy) with a few representa-
tive GCR species (56Fe, 28Si, 16O and protons).
2) Extend these studies to other particle energies and beams 
(4He, 20Ne, 48Ti, etc.) to establish the radiation quality depen-
dence of these processes.
3) Test the impact of chronic or meaningful fractionated expo-
sures as compared to single dose exposure for different parti-
cle types including mixed radiation ﬁelds of protons and HZE 
particles, doses, and time points. Biological time scales impor-
tant in brain function should be considered in designing the 
duration of chronic exposures to be used.
4) If signiﬁcant effects are observed after 3), determine whether 
robust effects demonstrated in rodents are seen in the NHP.
5) For possible in-mission CNS risks, experiments simulating syn-
ergistic effects of space radiation and altered circadian rhythm 
and other spaceﬂight factors that might inﬂuence exposure 
thresholds for such effects should be considered.
6) Research on biological countermeasures to CNS risks should 
be pursued if 4) and/or 5) are conclusive on a risk at space 
relevant doses.
Finally there are many areas of neuroscience related to adverse 
health effects that have not been explored with HZE particle irradi-
ation including effects on axons, the role of DNA damage and cell 
cycle perturbations, more extensive studies on AD risk, neuroin-
ﬂammation, and autophagy, studies on protein clearance after ra-
diation exposures, changes to dendritic morphology and synapses, 
and studies of other late CNS effects besides AD to a name a few. 
We recommend that each of these areas be considered with a sig-
niﬁcant effort to fully understand the possible risks to crews on 
long duration missions in deep space.Acknowledgements
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